68 Large Investors Shied Away From STAAR Surgical Company (STAA)

STAAR Surgical Company (NASDAQ:STAA) produced a 160.66% rally since recording the worst price of $13.6. Thanks to the latest 4.02% increase, it now trades at $35.45. Throughout the trading on 02/11/2019, the share price floated between $33.94 and $35.63. This company shares are 48.1% off its target price of $52.5 and the current market capitalization stands at $1.54B. The recent change has given its price a 5.2% lead over SMA 50 and -34.35% deficit over its 52-week high. The stock witnessed 9.04% gains, -29.1% declines and -10.48% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found STAA’s volatility during a week at 4.42% and during a month it has been found around 4.74%.

STAAR Surgical Company (STAA) Top Holders

Institutional investors currently hold around $1.32 billion or 87% in STAA stock. Look at its top three institutional owners. Broadwood Capital Inc owns $369.95 million in STAAR Surgical Company, which represents roughly 24.02% of the company’s market cap and approximately 28.05% of the institutional ownership. Similar statistics are true for the second largest owner, Palo Alto Investors Lp, which owns 3,521,565 shares of the stock are valued at $120.02 million. The third largest holder is Blackrock Inc., which currently holds $106.03 million worth of this stock and that ownership represents nearly 6.88% of its market capitalization.

STAAR Surgical Company 13F Filings

At the end of September reporting period, 123 institutional holders increased their position in STAAR Surgical Company (NASDAQ:STAA) by some 6,850,717 shares, 68 decreased positions by 6,525,811 and 19 held positions by 25,319,404. That puts total institutional holdings at 38,695,932 shares, according to SEC filings. The stock grabbed 46 new institutional investments totaling 2,256,227 shares while 19 institutional investors sold out their entire positions totaling 331,155 shares.

STAAR Surgical Company (NASDAQ:STAA) Insider Trades

Multiple company employees have indulged in significant insider trading. STAAR Surgical Company disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Wall William P has sold 5,000 shares of STAAR Surgical Company (STAA) in trading session dated Aug. 20, 2018. These shares are worth $206,750 and were traded at $41.35 each. The SEC filing shows that Andrews Deborah J performed a sale of 13,331 shares. The CFO disposed these shares by way of transaction on May. 03, 2018. The company’s shares were given away at $17.6 per share worth to an income of some $234,626 on account of Andrews Deborah J.

CFO, Andrews Deborah J, sold 333 common shares of STAAR Surgical Company (STAA) in the open market. In a transaction dated Mar. 22, 2018, the shares were put up for sale at an average price of $16.05, raking in a sum of $5,345. After this sale, 15,667 common shares of STAA are directly owned by the insider, with total stake valued at $555,395.

In the transaction dated Mar. 22, 2018, the great number of shares disposed came courtesy the Chief Legal Officer; Gesten Samuel J disposed a total of 2,833 shares at an average price of $16.05, amounting to approximately $45,470. The insider now directly owns 38,316 shares worth $1,358,302.

STAAR Surgical Company (STAA) Analyst Guide

Several analysts have released their opinion on STAAR Surgical Company (NASDAQ:STAA), with 5 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1 average brokerage recommendation.